In this converse from MS Daily life you can listen to about investigation into new disorder modifying therapies (DMTs) for numerous sclerosis.
Dr Jeremy Chataway (University College or university London) and Professor Gavin Giovannoni (Queen Mary University of London) communicate about latest developments in this location.
More than the earlier couple several years we’ve observed remedy alternatives fast develop for folks with relapsing remitting MS, with the licensing of Tysabri and Gilenya (the to start with oral pill). In the past calendar year alone we have observed 3 new medicine certified – Aubagio (teriflunomide), Lemtrada (alemtuzumab) and Tecfidera (dimethyl fumarate), giving a lot more remedy decision than at any time ahead of.
The session is chaired by Michelle Mitchell, Main Govt of the MS Modern society. It also options contributions from Nick Rijke, Director of Policy and Study at the MS Modern society and Mary Burke, person with relapsing remitting MS.
For a lot more information about DMTs and how you can get entry to them: http://www.treatmerightms.org.uk/
Observe all the talks from MS Daily life and a lot more: http://www.mssociety.org.uk/ms-investigation/investigation-blog site/2014/05/ms-life-2014-highlights-science-zone
I learned a lot from this. Thanks. It's nice to see my neurologist Prof GG sharing some interesting information. I'm still not convinced that Lemtrada is worth the risk. Tysabri and Tecfidera seem to be a less volatile form of treatment.
this site is very interesting site!!
Where exactly i can find this presentation in mssociety blog?
Thank you.
Check out this helpful talk on MS Research into Disease Modifying Treatments, recorded live at MS Life 2014.
http://www.mssociety.org.uk/ms-news-research/ms-research